Mixed lineage leukemia protein in normal and leukemic stem cells

Area of Science:

• Hematology
• Oncology
• Molecular Biology

Background:

• Transcription factor mutations in hematopoietic stem cells drive acute leukemia.
• Mixed lineage leukemia (MLL) gene rearrangements, including fusions, partial tandem duplications (PTD), amplification, and deletions, are frequent oncogenic events in leukemia.
• MLL rearrangements are associated with poor prognosis, but research on MLL-PTD and MLL amplification lags behind MLL-fusions.

Purpose of the Study:

• To review the key features of wild-type MLL and its rearranged forms.
• To focus on the roles of MLL-PTD and MLL amplification in normal and malignant hematopoiesis.
• To highlight the limited progress and research gaps for MLL amplification and deletion.

Main Methods:

• Literature review of existing research on MLL gene.
• Analysis of wild-type MLL protein functions.
• Examination of MLL rearrangements, specifically MLL-PTD and MLL amplification.

Main Results:

• Extensive research exists on wild-type MLL and MLL-fusions, advancing understanding of their roles in hematopoiesis.
• Research on MLL-PTD and MLL amplification is less advanced.
• Mouse models are unavailable for MLL amplification and internal exonic deletion, hindering progress.

Conclusions:

• Understanding MLL rearrangements is crucial for leukemia pathogenesis.
• Further research is needed on MLL-PTD and MLL amplification to develop targeted therapies.
• The lack of animal models for certain MLL abnormalities presents a significant challenge.